Showing 41 - 60 results of 294 for search 'Delivery Hero~', query time: 2.36s Refine Results
  1. 41

    Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice by Dai Fukumura, Rakesh K Jain, Jun Ren, Xinyue Dong, Zohreh Amoozgar, Somin Lee, Meenal Datta, Sylvie Roberge, Mark Duquette

    Published 2023-03-01
    “…In fact, the US FDA (Food and drug administration) has approved seven different combinations of anti-VEGF drugs and immune checkpoint blockers for liver, kidney, lung and endometrial cancers in the past 3 years. Here, we tested the hypothesis that anti-VEGF therapy can improve the delivery and efficacy of CAR-T cells in immunocompetent mice bearing orthotopic GBM tumors. …”
    Get full text
    Article
  2. 42
  3. 43
  4. 44

    An Evaluation of the Contribution of African Traditional Medicine to Healthcare Delivery: A Case Study of Selected Herbal Centres in Akuapem, Ghana by Henry Kwaku Adu-Offei, John Kwaku Opoku

    Published 2024-11-01
    “…Traditional medicine has become indispensable in contemporary healthcare delivery in both rural and urban communities in Ghana and beyond as it is patronized by people of various social statuses. …”
    Get full text
    Article
  5. 45

    Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? by Howard L Kaufman, Hongbin Wang, Dipongkor Saha, Samuel D Rabkin, Mia Borlongan, Uyen Le, Hans J Nauwynck

    Published 2024-05-01
    “…A better understanding of cytokine delivery by oHSV can help improve clinical benefit from oncolytic virus immunotherapy in patients with cancer.…”
    Get full text
    Article
  6. 46

    Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster by Shun Zhang, Xiaojie Wang, Tongyi Zhao, Chen Yang, Lulu Huang

    Published 2025-01-01
    “…The optimized mRNA sequences were assessed for protein expression levels in vitro and were subsequently used to develop a vaccine, named Vac07, encapsulated in a lipid nanoparticle (LNP) delivery system. …”
    Get full text
    Article
  7. 47

    Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism by Greice Krautz-Peterson, Yongrong Zhang, Kevin Chen, George A. Oyler, Hanping Feng, Charles B. Shoemaker

    Published 2012-01-01
    “…Here, we investigated the potential of engineering Clostridium difficile toxin B (TcdB) as a neuronal delivery vehicle by testing two recombinant TcdB chimeras. …”
    Get full text
    Article
  8. 48
  9. 49
  10. 50

    The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal... by Amin Mehrabian, Saba Dadpour, Mohammad Mashreghi, Javad Zarqi, Anis Askarizadeh, Ali Badiee, Leila Arabi, Seyedeh Alia Moosavian, Mahmoud Reza Jaafari

    Published 2023-04-01
    “…The presence of glutathione (GSH) receptors on the BBB surface has been demonstrated in numerous papers; consequently, products containing glutathione as a targeting ligand coupled with nanoliposomes are used to enhance drug delivery across the BBB. Here, the 5% pre‐inserted PEG2000‐GSH PEGylated liposomal doxorubicin was conducted according to 2B3‐101 being tested in clinical trials. …”
    Get full text
    Article
  11. 51

    Localized COUP‐TFII pDNA Delivery Modulates Stem/Progenitor Cell Differentiation to Enhance Endothelialization and Inhibit Calcification of Decellularized Allografts by Mengmeng Xing, Fei Wang, Ruowen Chu, He Wang, Yuyao Sun, Meng Qian, Huan Jiang, Adam C. Midgley, Guohao Dai, Qiang Zhao

    Published 2025-02-01
    “…Heparin‐polyethyleneimine nanoparticles (HEPI) are prepared as COUP‐TFII pDNA nanocarriers (COUP‐TFII@HPEI) and used to modify decellularized allografts, achieving long‐term and stable overexpression of COUP‐TFII. …”
    Get full text
    Article
  12. 52

    Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications by Hugo Felix Perini, Beatriz Sodré Matos, Carlo José Freire de Oliveira, Marcos Vinicius da Silva

    Published 2024-12-01
    “…Here, we address the therapeutic applications of biomimetic nanocarriers and their promising strategy for personalized medicine.…”
    Get full text
    Article
  13. 53
  14. 54

    Combined delivery of IL12 and an IL18 mutant without IL18BP-binding activity by an adenoviral vector enhances tumor specific immunity by Yan Cheng, Renjie Luo, Erguang Li

    Published 2025-01-01
    “…We previously reported that adenovirus armed with an IL18 variant (DR18) that overcomes IL18BP neutralizing effect displayed powerful therapeutic effects in local and distant tumors when delivered intratumorally. Here, we tested a combined delivery of IL12 and DR18 in tumor models since IL12 and IL18 are known to act synergistically in potentiating IFNγ production and antitumor immunity. …”
    Get full text
    Article
  15. 55
  16. 56
  17. 57

    Traumatic Uterine Rupture in Second Trimester: Two Departments, Two Patients, Two Survivors by Kaggwa H, Deogratious E, Ndiwalana BR, Luweesi H, Kaduyu P

    Published 2025-01-01
    “…Henry Kaggwa,1 Edemaga Deogratious,2 Billy Richard Ndiwalana,1 Henry Luweesi,2 Paul Kaduyu1 1Department of Obstetrics and Gynecology, Mengo Hospital, Kampala, Uganda; 2Department of Surgery, Mengo Hospital, Kampala, UgandaCorrespondence: Henry Kaggwa, Email kaggwahenry027@gmail.comAbstract: Uterine rupture is defined as the complete division of all three layers of the uterus: the endometrium, myometrium, and perimetrium. …”
    Get full text
    Article
  18. 58

    Bone‐Targeted Fluoropeptide Nanoparticle Inhibits NF‐κB Signaling to Treat Osteosarcoma and Tumor‐Induced Bone Destruction by Lin Li, Guangyu Rong, Xin Gao, Yiyun Cheng, Zhengwang Sun, Xiaopan Cai, Jianru Xiao

    Published 2025-01-01
    “…Intercepting the detrimental interplay between osteoclasts and osteosarcoma cells is considered as an option for osteosarcoma treatment. Here, a bone‐targeted fluoropeptide nanoparticle that can inhibit the nuclear factor kappa B (NF‐κB) signaling in both osteoclasts and osteosarcoma to address the above issue is developed. …”
    Get full text
    Article
  19. 59

    1.4 nm gold nanoparticle-antibody conjugates for in situ gold immunolabelling after transduction into living human cells by Groysbeck, Nadja, Haeberlé, Anne Marie, Ory, Stéphane, Hanss, Victor, Eltsov, Mikhael, Schultz, Patrick, Zuber, Guy

    Published 2023-10-01
    “…Several 1.4 nm gold nanoparticle-antibody conjugates were synthesised. Their abilities to bind to and label their corresponding epitopes within living cells after cytosolic delivery by electroporation are documented here.…”
    Get full text
    Article
  20. 60